BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 22564708)

  • 1. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
    Soetikno V; Watanabe K; Sari FR; Harima M; Thandavarayan RA; Veeraveedu PT; Arozal W; Sukumaran V; Lakshmanan AP; Arumugam S; Suzuki K
    Mol Nutr Food Res; 2011 Nov; 55(11):1655-65. PubMed ID: 22045654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
    Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
    Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKAP150 mobilizes cPKC-dependent cardiac glucotoxicity.
    Zeng C; Wang J; Li N; Shen M; Wang D; Yu Q; Wang H
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(4):E384-97. PubMed ID: 25005497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level.
    Feng B; Chen S; Chiu J; George B; Chakrabarti S
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1119-26. PubMed ID: 18413674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway.
    Gbr AA; Abdel Baky NA; Mohamed EA; Zaky HS
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):349-360. PubMed ID: 32984914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
    Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
    Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
    PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
    Manna P; Sinha M; Sil PC
    Toxicology; 2009 Mar; 257(1-2):53-63. PubMed ID: 19133311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice.
    Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G
    Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of β-casomorphin-7 on cardiomyopathy of streptozotocin-induced diabetic rats via inhibition of hyperglycemia and oxidative stress.
    Han DN; Zhang DH; Wang LP; Zhang YS
    Peptides; 2013 Jun; 44():120-6. PubMed ID: 23562714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.
    Chiu J; Khan ZA; Farhangkhoee H; Chakrabarti S
    Nutrition; 2009 Sep; 25(9):964-72. PubMed ID: 19268536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.
    Cheng Y; Guo S; Liu G; Feng Y; Yan B; Yu J; Feng K; Li Z
    Int J Mol Med; 2012 Oct; 30(4):870-6. PubMed ID: 22859217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.
    Liu Y; Lei S; Gao X; Mao X; Wang T; Wong GT; Vanhoutte PM; Irwin MG; Xia Z
    Clin Sci (Lond); 2012 Feb; 122(4):161-73. PubMed ID: 21892921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.